# Alys Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alys-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.alyspharma.com
- Total disclosed funding: $100M
- Latest round: Seed (Feb 12, 2024)
- Investors on record: 1

## About

Founded in 2024 and based in Massachusetts, US, Alys Pharmaceuticals, Inc. operates as a provider of science-based treatments for immunodermatology. In February 2024, Alys Pharmaceuticals, Inc. raised USD 100 million in venture funding from new investor Medicxi Ventures.

Alys Pharmaceuticals provides a research and development pipeline comprising an active program targeting various dermatologic indications. Through the integration of multiple platform technologies, the company develops therapies that transform the treatment landscape across a spectrum of dermatological conditions, addressing unmet medical needs and improving patient outcomes.

The company plans to use the venture funding to support the advancement of its immuno-dermatology solutions.

## Funding rounds

- Seed, Feb 12, 2024, $100M — Medicxi

## Investors

- Medicxi (https://capitalatlas.ai/funds/medicxi) — Seed